NCT05257876

Brief Summary

The study will follow the MRC Framework to develop an evidence-based BE intervention protocol to help breast cancer survivors with better management of cancer-related chronic pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable chronic-pain

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 25, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 12, 2023

Completed
Last Updated

February 16, 2024

Status Verified

February 1, 2024

Enrollment Period

7 months

First QC Date

February 3, 2022

Last Update Submit

February 14, 2024

Conditions

Keywords

Pain ManagementChronic PainBreast NeoplasmsCancer survivorsBreathing Exercises

Outcome Measures

Primary Outcomes (10)

  • Feasibility: Time taken to recruit planned sample

    The time that was taken to recruit the planned sample size of participants

    Immediately after the allocation of the last subject

  • Feasibility: Referral rate

    The number of referrals made by clinicians in different departments divided by all referrals

    Immediately after the referral of the last subject

  • Feasibility: Recruitment rate

    Proportion of subjects who participated in the study from all subjects eligible for participation

    Immediately after the recruitment of the last subject

  • Feasibility: Retention rate

    Proportion of participants who completed the whole study divided by all subjects who enrolled in the study

    At the follow-up assessment 4 weeks after the intervention completion (T3)

  • Feasibility: Dropout rate

    The number of subjects who dropped out after randomization divided by all subjects who enrolled in the study

    At the follow-up assessment 4 weeks after the intervention completion (T3)

  • Reasons for dropping out

    Feedback from the dropout subjects to identify their reasons for dropping out

    Immediately once a dropout occurs

  • Feasibility of the questionnaires

    The percentage of missing values for each item of the scales used, including the Brief Pain Inventory (BPI), Quality of life Cancer Survivors Version (QOL-CSV), Functional Assessment Cancer Therapy-Breast (FACT-B), and Hospital Anxiety and Depression Scale (HADS)

    At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)

  • Feasibility: Adherence rates

    the percentage of BE sessions performed by participants divided by the total number of BE sessions required

    Immediately after completion of the 4-week intervention (T2)

  • Participants' feedback

    Participants' feedback on and satisfaction with the intervention using a specifically designed feedback form

    Immediately after completion of the 4-week intervention (T2)

  • Adverse events associated with the intervention

    Data will be collected from the participants' BE logbooks and supplemented by information collected during weekly telephone contact

    Immediately once an adverse event occurs

Secondary Outcomes (4)

  • Chronic pain

    At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)

  • Quality of life of breast cancer survivors ( using tool 1)

    At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)

  • Quality of Life of breast cancer survivors ( using tool 2)

    At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)

  • Anxiety and Depression

    At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants in the intervention group will receive breathing exercise training, pain information booklet, and usual care.

Other: Breathing exercise

Control group

NO INTERVENTION

Participants in the control group will receive pain information booklet and usual care.

Interventions

Participants will receive breathing exercise training, and a 4-week self exercise

Intervention group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsGender eligibility is based on the physical appearance.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female breast cancer survivors ≥18 years age;
  • has a confirmed diagnosis of breast cancer at stage I, II or IIIa;
  • has been experiencing pain since cancer diagnosis constantly or intermittently for ≥3 months, with the average pain intensity in the last seven days on a numerical scale ≥4/10 ("0" indicates no pain and "10" indicates the worst pain);
  • has completed active anticancer treatment (such as chemotherapy, radiotherapy, surgery) for at least three months;
  • agrees to participate in the research and is willing to give informed consent;
  • can read and understand Mandarin Chinese.

You may not qualify if:

  • extremely weak and unable to perform the breathing exercises;
  • mentally incapable (i.e., unable to follow the study instructions);
  • has scheduled pain management interventions, such as having a procedure or operation;
  • receiving other pain relief treatments, such as acupuncture, yoga, qigong, exercise program, etc.;
  • has any pre-existing chronic pain conditions before cancer diagnosis, such as arthritis, rheumatoid arthritis, chronic low back pain, migraines, trigeminal neuralgia, fibromyalgia, joint dysfunction, Complex Regional Pain Syndrome, endometriosis, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Affiliated Hospital Of Southwest Medical University

Luzhou, Sichuan, 646000, China

Location

Related Publications (1)

  • Wang H, Tan JB, Wang T, Liu XL, Bressington D, Zheng SL, Huang HQ. Feasibility and potential effects of breathing exercise for chronic pain management in breast cancer survivors: study protocol of a phase II randomised controlled trial. BMJ Open. 2022 Dec 14;12(12):e064358. doi: 10.1136/bmjopen-2022-064358.

MeSH Terms

Conditions

Chronic PainBreast NeoplasmsAgnosia

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Professor Jing-Yu (Benjamin) Tan, PhD

    Charles Darwin University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Open-labelled parallel pilot RCT
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2022

First Posted

February 25, 2022

Study Start

January 1, 2023

Primary Completion

August 12, 2023

Study Completion

August 12, 2023

Last Updated

February 16, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

It needs to get the participants' consent if the data is shared with other researchers.

Locations